143 related articles for article (PubMed ID: 22522382)
21. Induction of antinuclear antibodies by de novo autoimmune hepatitis regulates alloimmune responses in rat liver transplantation.
Nakano T; Goto S; Lai CY; Hsu LW; Tseng HP; Chen KD; Chiu KW; Wang CC; Cheng YF; Chen CL
Clin Dev Immunol; 2013; 2013():413928. PubMed ID: 24454474
[TBL] [Abstract][Full Text] [Related]
22. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies.
Muratori L; Longhi MS
J Autoimmun; 2013 Oct; 46():74-80. PubMed ID: 23871639
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic alterations of regulatory T cells in autoimmune hepatitis: causal or associated with treatment and remission?
Sebode M; Peiseler M; Weiler-Normann C; Schramm C; Lohse AW; Herkel J
Hepatology; 2015 Feb; 61(2):736-7. PubMed ID: 25044332
[No Abstract] [Full Text] [Related]
24. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators?
Vierling JM
Hepatology; 2011 Feb; 53(2):385-8. PubMed ID: 21274860
[No Abstract] [Full Text] [Related]
25. Autoimmune hepatitis: 50 Years of (slow) progress.
Gershwin ME; Krawitt EL
Hepatology; 2014 Mar; 59(3):754-6. PubMed ID: 24712041
[No Abstract] [Full Text] [Related]
26. Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.
Behairy BE; El-Araby HA; Abd El Kader HH; Ehsan NA; Salem ME; Zakaria HM; Khedr MA
Ann Hepatol; 2016; 15(5):682-90. PubMed ID: 27493106
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune hepatitis.
Vergani D; Longhi MS; Bogdanos DP; Ma Y; Mieli-Vergani G
Semin Immunopathol; 2009 Sep; 31(3):421-35. PubMed ID: 19533129
[TBL] [Abstract][Full Text] [Related]
28. T regulatory cells.
Thornton AM
Curr Biol; 2005 Aug; 15(15):R582. PubMed ID: 16085474
[No Abstract] [Full Text] [Related]
29. Cutting edge issues in autoimmune hepatitis.
Vergani D; Mieli-Vergani G
Clin Rev Allergy Immunol; 2012 Jun; 42(3):309-21. PubMed ID: 21207191
[TBL] [Abstract][Full Text] [Related]
30. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.
Liberal R; Grant CR; Holder BS; Cardone J; Martinez-Llordella M; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2015 Sep; 62(3):863-75. PubMed ID: 25953611
[TBL] [Abstract][Full Text] [Related]
31. The Foxp3 interactome: a network perspective of T(reg) cells.
Hori S
Nat Immunol; 2012 Oct; 13(10):943-5. PubMed ID: 22990900
[No Abstract] [Full Text] [Related]
32. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
[TBL] [Abstract][Full Text] [Related]
33. Reply: To PMID 23925905.
Golding A; Shavach EM; Hasni S; Illei G
Arthritis Rheumatol; 2014 May; 66(5):1403-4. PubMed ID: 24470345
[No Abstract] [Full Text] [Related]
34. FoxP3 mRNA expression in regulatory T cells from patients with tuberculosis.
Gazzola L; Tincati C; Gori A; Saresella M; Marventano I; Zanini F
Am J Respir Crit Care Med; 2006 Aug; 174(3):356; author reply 357. PubMed ID: 16864720
[No Abstract] [Full Text] [Related]
35. Treg/Th17 imbalance is associated with poor autoimmune hepatitis prognosis.
Liu Y; Yan W; Yuan W; Wang P; Huang D; Luo X; Ning Q
Clin Immunol; 2019 Jan; 198():79-88. PubMed ID: 30453094
[No Abstract] [Full Text] [Related]
36. Fox family ties.
Williams CB; Chatila TA
Cell Res; 2013 Apr; 23(4):452-4. PubMed ID: 23318581
[TBL] [Abstract][Full Text] [Related]
37. Reply: To PMID 22564681.
Massoud AH; Kaufman GN; Mourad MW; Piccirillo C; Mazer BD
J Allergy Clin Immunol; 2013 Apr; 131(4):1257-8. PubMed ID: 23465665
[No Abstract] [Full Text] [Related]
38. Reply: To PMID 23787765.
Grant CR; Liberal R; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2015 Feb; 61(2):737-8. PubMed ID: 25042541
[No Abstract] [Full Text] [Related]
39. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
40. Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
Diestelhorst J; Junge N; Schlue J; Falk CS; Manns MP; Baumann U; Jaeckel E; Taubert R
PLoS One; 2017; 12(7):e0181107. PubMed ID: 28700730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
